stroke

A new tool helps stem cells integrate with host neural circuitry after implantation in mice.

A small study reports that, among children who had left-hemisphere damage as newborns, the complementary region of the right hemisphere appears to compensate and protect language development.

If a system tested in decapitated pigs ever gets to human clinical trials, neuroscientific and ethical reasons point to testing babies before adults.

The NIH epidemiologist has worked to ensure genetic health and population genetics studies contain data from African—not just European—populations.

The scientists involved have hired lawyers to fight the conclusions of a recent investigation into some studies of Diovan in Japan.

Analysis of DNA samples from more than 520,000 people brings the number of known stroke-risk loci to 32. 

Animal experiments published in a handful of cardiovascular journals mostly ignore NIH guidelines.

A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?

A bidirectional link between the brain and the gut can improve or worsen brain injury in mice, researchers report.

In the introduction to the book, author Eliezer J. Sternberg illustrates what can happen when the brain’s processing centers are damaged.

What can neuroscientists learn from the masters and other artists?

Scientists present new recipes for directly converting glial cells to neurons in mouse brains.

See human brains age in week-by-week time lapse images that divulge the existence of tiny strokes that damage white matter.

A study implicates the breaking up of bacterial biofilms on fatty plaques in arteries as causing stroke or heart attack following stress.

Researchers unravel the biology of beauty and art.

The iconic Framingham Heart Study, the longest-running cardiovascular study in the country, has been hit with a $4 million budget cut.

Researchers show that the Mediterranean diet may counteract the increased risk of cardiovascular disease and stroke in people with a certain genetic variant.

Long-term stroke patients involved in a small-scale clinical trial of a neural stem-cell therapy show signs of recovery.

A University of Wisconsin neuroscientist is found guilty of falsifying Western blots as part of his stroke research, and has requested the retraction of two papers.

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.